Juva Life Inc.

As of March 31, 2023, Juva Life Inc. carries a market capitalization of 9.44M, placing it among publicly traded companies globally. Its enterprise value stands at 16.88M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2023, Juva Life Inc. has 164.07M shares outstanding.

These figures are as of March 31, 2023. The price-to-sales ratio is 1.58, and the price-to-book ratio stands at 1.11.

These figures are as of March 31, 2023. The EV/Sales ratio of 2.85 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 16.88M versus a market cap of 9.44M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2023, Juva Life Inc. maintains a current ratio of 0.78, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 97.97, indicating elevated leverage, while an interest coverage ratio of -3.63 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2023, Juva Life Inc. posted a negative return on equity (ROE) of -116.12, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -47.79, reflecting losses generated across the asset base. The company generates approximately 246,379.29 in revenue per employee across its workforce of 24.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 6.13 indicates how many times Juva Life Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2023, Juva Life Inc. recorded 106,827.00 in income tax expense. The company reported a pretax loss of -9.26M and -9.36M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended March 31, 2023, Juva Life Inc. generated 5.91M in revenue and converted that into -9.36M in net income, yielding earnings per share of -0.06. EBITDA reached -5.74M, while operating income came in at -8.34M.

As of March 31, 2023, Juva Life Inc. holds 888,314.00 in cash and equivalents against 8.33M in total debt, resulting in a net debt position of 7.33M. Total book value stands at 8.50M, with working capital of -701,820.00 providing operational flexibility.

Juva Life Inc. produced -5.34M in operating cash flow over the twelve months ended March 31, 2023. After subtracting -5.31M in capital expenditures, free cash flow totaled -10.64M - equivalent to -0.07 per share.

Over the twelve months ended March 31, 2023, Juva Life Inc. posted a gross margin of 15.79, reflecting its pricing power and cost economics. The operating margin of -140.98 and net profit margin of -158.34 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2023. Free cash flow yield is negative at -113.87: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -111.71, meaning Juva Life Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of March 31, 2023, Juva Life Inc. has an Altman Z-Score of -4.27, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.